Meningitis News and Research

Latest Meningitis News and Research

HIV-negative babies born to HIV-positive mothers have lower antibody levels for some infections, study finds

"Babies who are exposed to HIV at birth but don't become infected with the virus have lower levels of antibodies to diseases such as whooping cough, tetanus and pneumococcus," according to a study published in the Feb. 9 issue of the Journal of the American Medical Association (JAMA), HealthDay News/U.S. News & World Report.

10 Feb 2011

Babies born to HIV-infected mothers have lower antibody levels against bacterial infections

Babies whose mothers have HIV, but who are not HIV-infected themselves, are born with lower levels of specific proteins in their blood called antibodies, which fight infection, compared with babies not exposed to HIV, a new study has found.

9 Feb 2011

Loyola inaugurates clinic exclusively to treat children with headaches

Fortunately, in most cases the causes of childhood headaches are usually no cause for alarm, Schnitzler said. Children can get headaches from stress, anxiety, inadequate sleep, vision problems, caffeine or food sensitivities. To help pinpoint the cause, Loyola has opened a clinic that's exclusively devoted to treating children with headaches.

31 Jan 2011

UK government, Bill & Melinda Gates Foundation to support efforts to stamp out polio

British Prime Minister David Cameron said today that the United Kingdom would double its current contribution to polio eradication.

29 Jan 2011

Opinions: GAVI; Haitian women; Clinton's foreign policy

"Vaccines are among the greatest scientific contributions to human welfare. They are also some of the largest humanitarian contributions of developed nations to the rest of the world. So it is unfortunate that a decade of vaccine controversy has overshadowed a decade of vaccine miracles," Washington Post columnist Michael Gerson writes in an opinion piece reflecting on the contributions of the GAVI Alliance over the past decade.

21 Jan 2011

WHO Director-General opens executive board session with calls for reform

Kicking off a nine-day annual WHO executive board meeting Monday, WHO Director-General Margaret Chan called for the board to consider areas where the agency can redirect resources in a more targeted manner so as to achieve greater outcomes, Reuters reports.

19 Jan 2011

Cataloguing microbes in gut could lead to cause of necrotizing enterocolitis

Scientists have for the first time sequenced and reconstructed the genomes of most of the microbes in the gut of a premature newborn and documented how the microbe populations changed over time.

14 Jan 2011

Study reports long-term complications in childhood survivors of bacterial meningitis

Nearly half of children who survive an episode of bacterial meningitis experience persistent behavioral, intellectual, or other complications, reports a study in the January issue of The Pediatric Infectious Disease Journal.

14 Jan 2011

Bill and Melinda Gates Foundation grants $1.5million to Liverpool University for bacterial study

A University of Liverpool-led consortium has received $1.5million from the Bill & Melinda Gates Foundation to study a bacterium that causes serious disease and epidemics in sub-Saharan Africa.

14 Jan 2011

Hydrocephalus in Ugandan children linked to farm animals, previous bacterial infection

Hydrocephalus in Ugandan children and other developing countries is seasonal, linked to farm animals and in part, caused by previous bacterial infection, according to an international team of researchers from Uganda and the United States, who believe that the best approach to this problem is prevention.

3 Jan 2011

Sinovac's inactivated EV71 vaccine clinical trial against HFMD receives Chinese SFDA approval

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today that it received approval from the China State Food and Drug Administration (SFDA) to commence clinical trials for its proprietary inactivated EV71 vaccine against Hand, Foot and Mouth Disease (HFMD).

28 Dec 2010

Pfizer seeks FDA and EMA approval for expanded use of Prevnar 13 for pneumococcal disease

Pfizer Inc today announced that it has submitted supplemental applications to both the United States Food and Drug Administration (FDA) and the European Medicines Agency (EMA) to expand the use of Prevnar 13® (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) to adults 50 years of age and older for the prevention of pneumococcal disease caused by the 13 serotypes contained in the vaccine.

23 Dec 2010

AIDS patients with serum biomarkers are predisposed to immune reconstitution inflammatory syndrome

A study in this week's PLoS Medicine suggests that AIDS patients with cryptococcal meningitis who start HIV therapy are predisposed to immune reconstitution inflammatory syndrome - an exaggerated inflammatory immune response that kills up to one-third of affected people - if they have biomarkers in their blood showing evidence of a damaged immune system that is not capable of clearing the fungal infection.

22 Dec 2010

Prevenar 13 launched in first childhood immunization program for PD in Nicaragua

Pfizer Inc. announced that Prevenar 13 (Pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]) was introduced into the first childhood immunization program for pneumococcal disease (PD) in the developing world under the auspices of the Advance Market Commitment (AMC) when Nicaragua launched its program today. The AMC is an innovative program which involves private-public partnerships to help make newer vaccines available on a sustainable, affordable and accelerated basis to the least developed countries.

13 Dec 2010

Vaccine World Summit to be held in New Delhi 1-3 March, 2011

From the 1st to the 3rd of March 2011, vaccine leaders from developing and developed world will meet at Vaccine World Summit in New Delhi. The event will be hosted by IMAPAC, in partnership with DCVMN (Developing Countries Vaccine Manufacturers Network).

8 Dec 2010

Financial Times contrasts 'bottom up' and 'top down' approaches to developing country drugs

The Financial Times contrasts the model of drug development for developing countries being used by non-profit groups like the Meningitis Vaccine Project (MVP), which recently rolled out the MenAfriVac, to that of some pharmaceutical companies.

8 Dec 2010

Campaign to inoculate millions across Africa against meningitis kicks off in Burkina Faso

On Monday, a campaign started in Burkina Faso to "inoculate tens of millions of West Africans with a new vaccine in what scientists hope will be the beginning of the end of ravaging meningitis epidemics" across the continent, the New York Times reports.

7 Dec 2010

One shot, cheap meningitis vaccine now available in Africa

As a boon to millions of children who die of meningitis, a cheap new vaccine for bacterial meningitis debuted today with the launching of an immunization drive in the West African country of Burkina Faso, in the first stage of an effort that could rid sub-Saharan Africa of the primary cause of meningitis, the World Health Organization (WHO) announced.

6 Dec 2010

MenAfriVac to help health workers eliminate meningococcal A epidemics

The West African nation of Burkina Faso today became the first country to begin a nationwide campaign to introduce a new meningitis vaccine that promises to rid the entire region of the primary cause of epidemic meningitis. The first vaccine designed specifically for Africa, MenAfriVac is expected to help health workers eliminate meningococcal A epidemics in the 25 countries of the meningitis belt, stretching from Senegal in the west to Ethiopia in the east.

6 Dec 2010

New laboratory test for pregnant women to detect GBS infections

A more rapid laboratory test for pregnant women to detect Group B strep (GBS), the most common cause of life-threatening infections in newborns, is being studied by researchers at The University of Texas Health Science Center at Houston (UTHealth).

29 Nov 2010

Meningitis News and Research

Latest Meningitis News and Research

HIV-negative babies born to HIV-positive mothers have lower antibody levels for some infections, study finds

Babies born to HIV-infected mothers have lower antibody levels against bacterial infections

Loyola inaugurates clinic exclusively to treat children with headaches

UK government, Bill & Melinda Gates Foundation to support efforts to stamp out polio

Opinions: GAVI; Haitian women; Clinton's foreign policy

WHO Director-General opens executive board session with calls for reform

Cataloguing microbes in gut could lead to cause of necrotizing enterocolitis

Study reports long-term complications in childhood survivors of bacterial meningitis

Bill and Melinda Gates Foundation grants $1.5million to Liverpool University for bacterial study

Hydrocephalus in Ugandan children linked to farm animals, previous bacterial infection

Sinovac's inactivated EV71 vaccine clinical trial against HFMD receives Chinese SFDA approval

Pfizer seeks FDA and EMA approval for expanded use of Prevnar 13 for pneumococcal disease

AIDS patients with serum biomarkers are predisposed to immune reconstitution inflammatory syndrome

Prevenar 13 launched in first childhood immunization program for PD in Nicaragua

Vaccine World Summit to be held in New Delhi 1-3 March, 2011

Financial Times contrasts 'bottom up' and 'top down' approaches to developing country drugs

Campaign to inoculate millions across Africa against meningitis kicks off in Burkina Faso

One shot, cheap meningitis vaccine now available in Africa

MenAfriVac to help health workers eliminate meningococcal A epidemics

New laboratory test for pregnant women to detect GBS infections

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Meningitis News and Research

Latest Meningitis News and Research

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Newsletters you may be interested in